Invited Paper Session
Rethinking Randomization: Bias, Ethics, and the Future of Clinical Trial Design.
Kerstine CarterOrganizerWenle ZhaoChair
Biopharmaceutical Section co: Statisticians in the Pharmaceutical Industryco: No Additional Sponsor Applied
5 Presentations
2:05 PM - 2:20 PM
Kerstine Carter (Boehringer Ingelheim Pharmaceuticals, Inc.)
2:20 PM - 2:35 PM
Wenle Zhao (The Medical University of South Carolina)
2:35 PM - 2:50 PM
Oleksandr Sverdlov (Novartis Pharmaceuticals Corporation)
3:05 PM - 3:20 PM
Johannes Krisam (Boehringer Ingelheim)
3:20 PM - 3:35 PM
Olga Kuznetsova (Merck & Co., Inc.)